Adam Cohen (b.1952) graduated in Pharmacy and Medicine from Leiden University. He subsequently joined the department of Clinical Pharmacology of the Wellcome Research Laboratories where he obtained experience in early drug development as well as larger trials in cardiovascular disease as a member of the ISIS Steering committee. He obtained a PhD degree from Leiden University (1986). He was trained in internal medicine and nephrology in King’s College Hospital London.
Since 1987 he is director of the Centre for Human Drug Research (CHDR), a research centre for early drug development and proof of concept studies in healthy subjects and patients. He is professor of Clinical Pharmacology at Leiden University and has a clinical attachment at the department of nephrology at Leiden University Medical Centre. He was vice-chairman of the Central Ethics Committee and the Competent Authority (CCMO) of the Netherlands between 1999 and 2011. He is Editor-in-Chief of the British Journal of Clinical Pharmacology and a member of the Health Council of the Netherlands and the Council for Medical Sciences of the Royal Academy of Sciences of the Netherlands. Adam is a non-executive board member of Omnicomm Inc in the USA and on the supervisory Board of the Rotterdam Eye Hospital. He is married to a physician and has three children and spend his spare time playing the clainet and bass clarinet.